A Novel Composite Endpoint of Toxicity- and Progression-Free Survival after B-Cell Maturation Antigen (BCMA)-Directed Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Multiple Myeloma

被引：0

作者：

Mohty, Razan ^{[1
]}

Junmin, Whiting ^{[2
]}

Saha, Aditi ^{[3
]}

Kim, Jongphil ^{[2
]}

Nishihori, Taiga ^{[1
]}

De Avila, Gabriel ^{[4
]}

Corallo, Salvatore ^{[1
]}

Dam, Marian ^{[1
]}

Marin, Jessica ^{[1
]}

Liu, Hien ^{[5
]}

Mokhtari, Sepideh ^{[6
]}

Jain, Michael D. ^{[1
]}

Perna, Fabiana ^{[7
]}

Blue, Brandon ^{[3
]}

Grajales-Cruz, Ariel F. ^{[4
]}

Castaneda, Omar ^{[8
]}

Shain, Kenneth ^{[4
]}

Baz, Rachid ^{[3
]}

Freeman, Ciara Louise L. ^{[8
]}

Alsina, Melissa ^{[5
]}

Locke, Frederick L. ^{[1
,5
]}

Hansen, Doris K.

Lazaryan, Aleksandr ^{[1
]}

机构：

[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplantat & Cellular Immun, Tampa, FL USA

[2] H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat & Bioinformat, Tampa, FL USA

[3] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA

[4] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[5] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[6] H Lee Moffitt Canc Ctr & Res Inst, Dept Neurooncol, Tampa, FL USA

[7] H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplantat & Cellular Immun, Indianapolis, IN USA

[8] H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplant & Cellular Immunot, Tampa, FL USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-184406

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：5

共 50 条

[21] CAR-T-Cell Therapy in Multiple Myeloma: B-Cell Maturation Antigen (BCMA) and Beyond
Mishra, Abhinava K.
Gupta, Ashna
Dagar, Gunjan
Das, Dayasagar
Chakraborty, Abhijit
Haque, Shabirul
Prasad, Chandra Prakash
Singh, Archana
Bhat, Ajaz A.
Macha, Muzafar A.
Benali, Moez
Saini, Kamal S.
Previs, Rebecca Ann
Saini, Deepak
Saha, Dwaipayan
Dutta, Preyangsee
Bhatnagar, Aseem Rai
Darswal, Mrinalini
Shankar, Abhishek
Singh, Mayank
VACCINES, 2023, 11 (11)
[22] Multiple Myeloma, Targeting B-Cell Maturation Antigen With Chimeric Antigen Receptor T-Cells
Shah, Urvi A.
Smith, Eric L.
CANCER JOURNAL, 2019, 25 (03): : 208 - 216
[23] Costs of care during chimeric antigen receptor T-cell therapy in relapsed or refractory B-cell lymphomas
Di, Mengyang
Potnis, Kunal C.
Long, Jessica B.
Isufi, Iris
Foss, Francine
Seropian, Stuart
Gross, Cary P.
Huntington, Scott F.
JNCI CANCER SPECTRUM, 2024, 8 (04)
[24] CARTITUDE-1: Phase 1b/2 Study of Ciltacabtagene Autoleucel, a B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy, in Relapsed/Refractory Multiple Myeloma
Madduri, Deepu
Berdeja, Jesus G.
Usmani, Saad Z.
Jakubowiak, Andrzej
Agha, Mounzer
Cohen, Adam D.
Stewart, A. Keith
Hari, Parameswaran
Htut, Myo
O'Donnell, Elizabeth
Munshi, Nikhil C.
Avigan, David E.
Deol, Abhinav
Lesokhin, Alexander M.
Singh, Indrajeet
Zudaire, Enrique
Yeh, Tzu-Min
Allred, Alicia J.
Olyslager, Yunsi
Banerjee, Arnob
Goldberg, Jenna D.
Schecter, Jordan M.
Jackson, Carolyn C.
Deraedt, William
Zhuang, Sen Hong
Infante, Jeffrey R.
Geng, Dong
Wu, Xiaoling
Carrasco, Marlene J.
Akram, Muhammad
Hossain, Farah
Rizvi, Syed
Fan, Frank
Jagannath, Sundar
Lin, Yi
Martin, Thomas, III
BLOOD, 2020, 136
[25] Metabolic parameters predict survival and toxicity in chimeric antigen receptor T-cell therapy-treated relapsed/refractory large B-cell lymphoma
Ababneh, Hazim S.
Ng, Andrea K.
Abramson, Jeremy S.
Soumerai, Jacob D.
Takvorian, Ronald W.
Frigault, Matthew J.
Patel, Chirayu G.
HEMATOLOGICAL ONCOLOGY, 2024, 42 (01)
[26] Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma
Hosen, Naoki
CANCERS, 2019, 11 (12)
[27] Chimeric antigen receptor T-cell therapy for multiple myeloma
Wang, Zehua
Chen, Chen
Wang, Lei
Jia, Yongxu
Qin, Yanru
FRONTIERS IN IMMUNOLOGY, 2022, 13
[28] Chimeric antigen receptor T-cell therapy for multiple myeloma
Hosen, Naoki
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 111 (04) : 530 - 534
[29] Chimeric antigen receptor T-cell therapy for multiple myeloma
Naoki Hosen
International Journal of Hematology, 2020, 111 : 530 - 534
[30] Chimeric Antigen Receptor T-cell Therapy for Multiple Myeloma
Atrash, Shebli
Ali, Syed Abbas
Usmani, Saad Z.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (01): : 21 - 34

← 1 2 3 4 5 →